BGT-002, CAS [[2127387-94-2]]

Produktübersicht

• Artikelname: BGT-002, CAS [[2127387-94-2]]
• Artikelnummer: MCE-HY-179591
• Hersteller Artikelnummer: HY-179591
• Alternativnummer: MCE-HY-179591-50MG,MCE-HY-179591-5MG,MCE-HY-179591-10MG,MCE-HY-179591-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: 326E

Produktbeschreibung

BGT-002 (326E) is an orally active dual ACLY inhibitor and PPARalpha agonist. BGT-002 reduces lipogenesis by inhibiting synthesis and promoting efflux. BGT-002 demonstrates efficacy in ameliorating metabolic dysfunction-associated steatohepatitis (MASH) and improving hyperlipidemia in vivo. BGT-002 can be used for hypercholesterolemia and MASH research[1][2][3].

Produkteigenschaften

• Molekulargewicht: 326.47
• Reinheit: 99.35
• CAS Nummer: [2127387-94-2]
• Formel: C19H34O4
• Target-Kategorie: ATP Citrate Lyase,PPAR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound